APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis.
Ma L, Palmer ND, Choi YA, Murea M, Snipes JA, Parks JS, Langefeld CD, Freedman BI. APOL1 Risk Variants Impair Multiple Mitochondrial Pathways in a Metabolomics Analysis. Kidney360. 2020 Dec 31; 1(12):1353-1362.